600,0
+0,00%
2026-10-16
Fundamental Analysis
33 / 100—Rubric: Manufacturing
Not rated — insufficient or unsupported data
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +0.8% | +33.3% | 3 / 3 | — | — | — | -0.4% | 0.00 | — | 0,0 | — | — | — | — | -4.71 | — |
| Pts | 0 | 4 | 12 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 600,0 (close price on 2026-10-16)EPS (TTM): −42,0
Financial charts
1.Revenue & growth
VND bn0,00Q2/26
1.Revenue & growth
VND bn0,00Q2/26
2.Profit & growth
VND bn-0,16Q2/26
3.Profit mix (Penman)
VND bn-0,72Q2/26
4.Margins & cost structure
%
5.Returns & cash cycle
% · days-0.2%Q2/26
6.Earnings quality & cash
VND bn-0,04Q2/26
7.Asset structure
VND bn177Q2/26
8.Funding & debt health
VND bn · times177Q2/26
9.Revenue backlog
VND bn0,52Q2/26
10.Valuation
times · %-19,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-9Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26